DEADLINE FOR RECEIPT OF ABSTRACTS
OF LATE BREAKING TRIALS: JUNE 10, 2002
Please note the following instructions for the preparation of abstracts:
- Abstracts must be written English and should be structured in
such a way as to include: Objectives, background, methods and
results and conclusions
- All abbreviations must be defined before being used as an abbreviation
in the text.
- The content of the abstract is solely the responsibility of
the author. The original abstract is reprinted exactly as provided.
It is therefore essential that the abstract is correctly typed.
Avoid errors, corrections and misspellings.
- Abstracts should contain no more than 250 words (1800 characters)
of text in the recommended font: Times New Roman, size 11 pts.
Do NOT use a smaller font size.
- Use single spacing.
- Title should be typed in UPPER CASE letters in bold and not
exceed more than 100 characters. Titles with more than 100 characters
will be truncated.
- The author/s names and institution/s should be in upper and
- Please clearly indicate the name of the presenting author, who
will be considered the contact person for all correspondence connected
with this abstract.
- No endnotes or frames are acceptable.
- Abstracts sent by fax will not be processed by the Secretariat
and will not be forwarded to the Scientific Committee for review.
The International Academy of Cardiology requires that audiences
at the Academy's educational programs be informed of a presenter's
(moderators, speakers, faculty, authors and contributors) academic
and professional affiliations, as well as other commercial relationships
relevant to the content of the material that is presented.
The policy allows the listener/attendee to be fully informed in
evaluating the information being presented. The situations may include,
but are not limited to 1) stock options or bond holdings in a for-profit
corporation or self-directed pension plan, 2) research grants, 3)
employment (full or part time), 4) ownership or partnership, 5)
consulting fees or other remuneration received by the presenter
or his/her immediate family, including support that may be provided
to attend the educational meeting, 6) nonremunerative positions
of influence such as officer, board member, trustee, or public spokesperson.
The disclosure will be shown as an indication (by an *) for those
presenters who have stated that a relationship(s) exists relevant
to the topic(s) being discussed.
Indicate any author(s) who has a possible conflict of interest
(see policy statement) by an asterisk (*) next to that author(s)
name in the heading of the abstract.
Abstract(s) may be submitted via this
website (PREFERRED METHOD)